“paratek-pharmaceuticals” Archives

in
Entry Author Date Location
Four New Drugs Are Around the Corner. Here’s What You Need to Know. 08/15/19 National
Bio Roundup: Nobel Prizes, Duchenne Steps, Guardant’s IPO & More 10/05/18 National
Paratek Wins Two FDA Drug Approvals for Three Conditions in Same Day 10/03/18 Boston
Paratek Eyes FDA Approval of Antibiotic After Advisory Panel Nod 08/08/18 Boston
Mid-FDA Review, Tetraphase Stumbles Again on Latest Phase 3 Setback 02/14/18 Boston
Bio Roundup: Drug Price Debates, NY Bio Blooms & CEOs Take Social Stand 08/25/17 National
Tetraphase Claws Back From Failed Study, Eyes FDA Filing With New Data 07/26/17 Boston
Bio Roundup: Obamacare Persists, FDA Approves, Vertex Wows & More 07/21/17 National
Forge Therapeutics Raises $15M to Take on Drug-Resistant Superbugs 04/25/17 San Diego
Zavante Plans FDA Filing After Antibiotic Hits Clinical Trial Goals 04/06/17 San Diego
With Fresh Pneumonia Data, Paratek To Seek 2018 Antibiotic Approval 04/03/17 Boston
Biotech Roundup: CRISPR’s 1st Trial, IPO Insiders, Zika & More 06/24/16 National
Paratek Shares Climb After Antibiotic Clears First Phase 3 Hurdle 06/16/16 Boston
More Biotechs Belly-Up These Days but Dendreon Still “One of a Kind” 12/02/14 National
Paratek Pharmaceuticals Receives $93,000,000 New Funding Round 07/15/14 Boston
West Coast Biotech Roundup: Seragon, Ambrx, Pregenen, and More 07/03/14 San Diego
Public Biotechs’ Finances Foundering, Epizyme Banks $32M, Paratek Cuts Deal with Novartis, & More Boston-Area Life Sciences News 10/09/09 Boston
Paratek Pharmaceuticals Garners $18,000,000 New Financing 04/16/08 Boston
$40 Million for Paratek Pharmaceuticals 10/25/07 Boston
Page 1 of 1